Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nifurtimox vs Benznidazole in Chagas Disease
NCT02369978Phase 3Unknown
- Sponsor
- Universidad Autónoma de Bucaramanga
- Start
- Aug 2015
- Primary completion
- Aug 2018
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of nifurtimox in Chagas disease, sponsored by Universidad Autónoma de Bucaramanga. Status: unknown.
02
Drugs
nifurtimox
03
Conditions
Chagas disease
Beyond the preview
Go deeper on NCT02369978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02369978.